These authors contributed equally to this work.
MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells†
Version of Record online: 18 FEB 2009
Copyright © 2009 American Association for the Study of Liver Diseases
Volume 50, Issue 1, pages 113–121, July 2009
How to Cite
Xu, T., Zhu, Y., Xiong, Y., Ge, Y.-Y., Yun, J.-P. and Zhuang, S.-M. (2009), MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology, 50: 113–121. doi: 10.1002/hep.22919
Potential conflict of interest: Nothing to report.
- Issue online: 23 JUN 2009
- Version of Record online: 18 FEB 2009
- Accepted manuscript online: 18 FEB 2009 12:00AM EST
- Manuscript Accepted: 12 FEB 2009
- Manuscript Received: 25 DEC 2008
- Ministry of Science and Technology of China. Grant Numbers: 2005CB724600, 2007AA02Z124
- National Natural Science Foundation of China. Grant Number: 30870964
- Ministry of Health of China. Grant Number: 2008ZX10002-019
Additional Supporting Information may be found in the online version of this article.
|HEP_22919_sm_SupportingDocument.doc||42K||Supporting Materials and Methods|
|HEP_22919_sm_SupportingTables.doc||94K||Supplementary Table 1. The Characteristics of Patients and Expression Status of miR-195 and Its Target Genes|
|HEP_22919_sm_SupportingFigure1.tif||264K||Supporting Figure 1. Specific detection of miR-195 by Northern blot. (A) Optimal hybridization temperature for specific detection of miR-195. Five pmols of synthetic RNA duplexes corresponding to miR-195 (lane 1) and miR-16 (lane 2) were separated on 15% denaturing polyacrylamide gel. Hybridizations were performed at indicated temperatures. The probe sequence was complementary to mature miR-195. (B) Sequence alignment of mature miRNA sequences of the miR-15/16/195 family members. Shading letters indicate the nucleotides same as mature miR-195.|
|HEP_22919_sm_SupportingFigure2.tif||902K||Supporting Figure 2. Expression level of miR-195 in different cell lines and normal human liver tissue. The same membrane was hybridized sequentially with miR-195 and U6 probe, as indicated on the left. HCC, hepatocellular carcinoma cell lines; U6, control for RNA loading.|
|HEP_22919_sm_SupportingFigure3.tif||190K||Supporting Figure 3. miR-195 expression reduces the number of viable cells. Cells were first transfected with NC or miR-195 duplex in a 24-well plate for 24 h, and then re-plated into 96-well plate at about 10% confluence, followed by Alamar Blue assay at every 24 h for 5 days, indicated as Day 1 to 5. *, P < 0.05; ***, P < 0.001, compared with NC-transfectants.|
|HEP_22919_sm_SupportingFigure4.tif||460K||Supporting Figure 4. miR-195 suppresses anchorage-independent cell growth. Representative pictures (A) and quantitative plots (B) are shown. Colonies larger than 150 μm in diameter were counted under 30 separate microscopic fields at 150 × magnification. ***, P < 0.001, compared with NC-transfectants.|
|HEP_22919_sm_SupportingFigure5.tif||210K||Supporting Figure 5. Ectopic expression of miR-195 induces accumulation of G1-cells in hepatocellular carcinoma (HCC), colorectal carcinoma (CRC) and osteosarcoma cells. For measurement of apoptotic cells, nuclear debris detected as sub-G1 peak were included. The percentage of G1 population is indicated within each histogram.|
|HEP_22919_sm_SupportingFigure6.tif||795K||Supporting Figure 6. Rb-E2F signaling is involved in miR-195-regulated G1/S transition in U-2OS cells. (A) Overexpression of miR-195 and knockdown of either cyclin D1, CDK6 or E2F3 increase the proportion of G1-cells. (B-C) miR-195 expression delays S-phase entry upon serum stimulation as assessed by FASC analysis (B) and BrdU incorporation assay (C). **, P < 0.01; ***, P < 0.001, compared with NC-transfectants. (D) Suppressed expression of endogenous cyclin D1, CDK6 and E2F3 by miR-195 or siRNA. Forty-eight hours after transfection with indicated RNA duplex, endogenous mRNA and protein levels of cyclin D1, CDK6 and E2F3 were analyzed by RT-PCR and Western Blot, respectively. (E) Phosphorylation of Rb protein is inhibited by miR-195. pRb, total Rb protein; ppRb, phosphorylated pRb. (F) Transactivation of E2F3 target genes is impeded by miR-195. The time point when serum was re-added was set as 0 h. Gene expression was examined by RT-PCR. β-actin or hPRT was used as internal control.|
|HEP_22919_sm_SupportingFigure7.tif||174K||Supporting Figure 7. Effect of miR-16 and miR-497 overexpression on the G1-population. HCT-116 cells were transfected with indicated miRNA duplex. Nocodazole (40 ng/ml) was added 32 h after transfection and cells were cultured for additional 16 h, followed by FASC analysis. ***, P < 0.001, compared with NC-transfectants.|
|HEP_22919_sm_SupportingFigure8.tif||148K||Supporting Figure 8. Putative miR-195 binding sites in the 3'UTR of respective genes. Mutation was generated in the complementary site (underlined) for the seed region of miR-195, as indicated.|
|HEP_22919_sm_SupportingFigure9.tif||443K||Supporting Figure 9. Examination of c-Myc expression by RT-PCR and Western blotting. (A) Expression of endogenous c-Myc in U-2OS, MHCC-97L and HCT-116 cells. (B) Knockdown of c-Myc expression in HCT-116 cells by 5 nM of siMyc. β-actin was used as internal control.|
|HEP_22919_sm_SupportingFigure10.tif||120K||Supporting Figure 10. Expression level of miR-195 and miR-16 after c-Myc knockdown. Levels of miR-195 and miR-16 were analyzed by real-time RT-PCR assay (PN 4373105 and PN 4373121, ABI, Foster City, CA) at indicated time points after transfection with siMyc or NC duplex in HCT-116 cells. RNU49 was used as internal control (PN 4373376, ABI). Fold change of expression indicates miRNA expression in si-Myc-transfectants relative to that of the matched NC-transfectants.|
|HEP_22919_sm_SupportingFigure11.tif||458K||Supporting Figure 11. Effect of miR-195, miR-16 or miR-497 overexpression on endogenous cyclin D1 expression of HCT-116 cells. Forty-eight hours after transfection with indicated RNA duplex, endogenous protein levels of cyclin D1 was assayed by Western Blot. β-actin was used as internal control.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.